Endoscopic ultrasonography in tandem with endoscopic retrograde cholangiopancreatography in the management of suspected distal obstructive jaundice.

Goals To examine the benefits and feasibility of endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) in tandem for distal obstructive jaundice. Materials and methods From September 2007 to August 2012, patients with suspected distal obstructive jaundice were randomized to single-session EUS-ERCP (group A), EUS, and ERCP in different sessions (group B), and an ERCP-only procedure (group C). Data were prospectively collected on the following parameters: ERCP-avoided, duration of procedure, the dose of propofol, complications, and diagnostic yield. Results A total of 180 patients were divided randomly into 60 patients in group A, 60 in group B, and 60 in group C. A total of four therapeutic ERCP were canceled after EUS. The ERCP procedural time in group A was shorter, although not significantly different from that in group B (group A vs. group B: 41.24 +/- 7.57 vs. 43.38 +/- 6.57 min; P > 0.05), but both were significantly less than that in group C (group C: 49.12 +/- 7.46 min; P < 0.05). The total procedural time did not differ significantly between group A and group B (70.05 +/- 15.35 vs. 73.70 +/- 15.12 min; P > 0.05), nor were there significant differences in the dose of propofol between them (group A vs. group B: 357.11 +/- 115.86 vs. 369.55 +/- 133.86 mg; P > 0.05). In all, 22 anesthetic complications and 21 endoscopic complications occurred without significant differences among the three groups (P > 0.05). Conclusion As a triaging or a screening tool, diagnostic EUS gives added benefit to therapeutic ERCP. EUS and ERCP in a tandem approach are safe and feasible in patients with suspected distal obstructive jaundice. Eur J Gastroenterol Hepatol 25:455-459 (C) 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins. European Journal of Gastroenterology & Hepatology 2013, 25:455-459